Terms: = Head and neck cancer AND HOXA9, HOX1, 3205, ENSG00000078399, HOX1G, P31269 AND Diagnosis
7 results:
1. Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review.
Lim I; Tan J; Alam A; Idrees M; Brenan PA; Coletta RD; Kujan O
J Oral Pathol Med; 2024 Feb; 53(2):90-106. PubMed ID: 38316046
[TBL] [Abstract] [Full Text] [Related]
2. Transcription Factor hoxa9 is Linked to the Calcification and Invasion of Papillary Thyroid Carcinoma.
Jin Y; Kim HK; Lee J; Soh EY; Kim JH; Song I; Chung YS; Choi YJ
Sci Rep; 2019 May; 9(1):6773. PubMed ID: 31043660
[TBL] [Abstract] [Full Text] [Related]
3. The clinical significance of hoxa9 promoter hypermethylation in head and neck squamous cell carcinoma.
Zhou C; Li J; Li Q; Liu H; Ye D; Wu Z; Shen Z; Deng H
J Clin Lab Anal; 2019 Jun; 33(5):e22873. PubMed ID: 30843252
[TBL] [Abstract] [Full Text] [Related]
4. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung cancer and Serum DNA.
Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
[No Abstract] [Full Text] [Related]
5. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.
Schussel J; Zhou XC; Zhang Z; Pattani K; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Brait M; Li R; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
Clin Cancer Res; 2013 Jun; 19(12):3268-75. PubMed ID: 23637120
[TBL] [Abstract] [Full Text] [Related]
6. NID2 and hoxa9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva.
Guerrero-Preston R; Soudry E; Acero J; Orera M; Moreno-López L; Macía-Colón G; Jaffe A; Berdasco M; Ili-Gangas C; Brebi-Mieville P; Fu Y; Engstrom C; Irizarry RA; Esteller M; Westra W; Koch W; Califano J; Sidransky D
Cancer Prev Res (Phila); 2011 Jul; 4(7):1061-72. PubMed ID: 21558411
[TBL] [Abstract] [Full Text] [Related]
7. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers.
Oka D; Yamashita S; Tomioka T; Nakanishi Y; Kato H; Kaminishi M; Ushijima T
Cancer; 2009 Aug; 115(15):3412-26. PubMed ID: 19472401
[TBL] [Abstract] [Full Text] [Related]
